In recent trading, shares of CareDx Inc (CDNA) have surpassed the average analyst 12-month target price of $52.33, currently valued at $52.36 per share. This movement invites potential reactions from analysts, including possible downgrades or a reassessment of target prices based on the company’s performance.
Analysts covering CareDx have a mixed range of target prices, with one predicting as low as $40.00 while another forecasts $64.00. The current analyst ratings show five strong buy ratings and three hold ratings, reflecting an average rating of 1.75 on a scale where 1 is a strong buy and 5 is a strong sell.
The information was compiled from data provided by Zacks Investment Research, highlighting the variability in analyst opinions as the market assesses the stock’s performance within a broader investment context.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
